Key facts
- This page summarizes Yehuda Eliya's Form 4 filing for Raphael Pharmaceutical Inc. (RAPH).
- 1 reported transaction and 0 derivative rows are listed below.
- Accepted by SEC: 25 Mar 2024, 16:01.
Yehuda Eliya - 25 Nov 2023 Form 4 Insider Report for Raphael Pharmaceutical Inc. (RAPH)
- Reporting relationship
- Director
- Issuer ticker
- RAPH
- Reported as of
- 25 Nov 2023
- Net transaction value
- +$60,000
- SEC form
- 4
- Accepted by SEC
- 25 Mar 2024, 16:01:51 UTC
- Prior SEC filing
- 13 Mar 2023
- Source filing
- View source filing
- Reporting owner signature
- /s/ Yehuda Eliya
Source evidence
Original filing metadata and source links for verification.
4 source fields
Reporting owner
1 detail
Key filing fact
Yehuda Eliya filed Form 4 for Raphael Pharmaceutical Inc. (RAPH) on 25 Mar 2024.
Change
- Previous filing in this sequence was filed on 13 Mar 2023.
- Current net transaction value: +$60,000.
Research use
- This tells you what this filing adds before you inspect full transaction and derivative tables.
- You can trace every row back to the original SEC filing document.
Evidence
Filed on Form 4
View source filing
Ownership activity is grounded in SEC Form 4 disclosures.
Reported non-derivative transactions
Shares, units, or other non-derivative securities reported in this filing.
RAPH
transaction
Common Stock
Award
- Transaction value
- $60,000
- Shares
- +150,000
- Change %
- +74%
- Price
- $0.4000*
- Shares after
- 352,000
- Date
- 25 Nov 2023
- Ownership
- Direct
* marks a reported price that did not pass the local price check.